Explore comprehensive insights into the gastric neuroendocrine tumor market, valued at USD 1.85 billion in 2024. The market is witnessing steady growth, supported by a favorable regulatory environment and a rise in clinical trials across the 8 major markets. Projected to grow at a CAGR of 3.34%, it is expected to reach USD 2.57 billion by 2034. This report provides a detailed analysis... https://www.expertmarketresearch.com/reports/gastric-neuroendocrine-tumor-market